Chop-deficient mice showed increased adiposity but no glucose intolerance

Obesity

Volumn 15, Issue 7, 2007, Pages 1647-1656

  Ariyama, Yasuyo ^a   Shimizu, Hiroyuki ^a,d   Satoh, Tetsurou ^a   Tsuchiya, Takafumi ^a   Okada, Shuichi ^a   Oyadomari, Seiichi ^b   Mori, Masataka ^c   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c SOJO UNIVERSITY   (Japan)

^d GUNMA UNIVERSITY   (Japan)

Author keywords

Adipocyte; CCAAT enhancer binding protein ; CCAAT enhancer binding protein ; Chop gadd153; High fat diet

Indexed keywords

DDIT3 PROTEIN, MOUSE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; UNCLASSIFIED DRUG;

ANIMAL; ANIMAL MODEL; ARTICLE; BODY WEIGHT; GENETICS; GLUCOSE TOLERANCE TEST; MOUSE; MOUSE MUTANT; OBESITY;

ANIMALS; BODY WEIGHT; GLUCOSE TOLERANCE TEST; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; OBESITY; TRANSCRIPTION FACTOR CHOP;

ANIMALIA; MUS;

EID: 34547961097     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.197     Document Type: Article

References (31)

1. Bray GA, Tartaglia LA. Medical strategies in the treatment of obesity. Nature. 2000;404:672-7.
2. Gullicksen PS, Della-Fera MA, Baile CA. Leptin-induced adipose apoptosis. Implications for body weight regulation. Apoptosis. 2003;8:327-35.
3. van der Sanden MHM, Houweling M, van Golde LM, Vaandrager AB. Inhibition of phosphatidylcholine synthesis induces expression of the endoplasmic reticulum stress and apoptosis-related protein CCAAT/enhancer- binding protein-homologous protein (CHOP/GADD153). Biochem J. 2003;369:643-50.
4. Luethy JD, Fargnoli J, Park JS, Fornace AJ Jr, Holbrooks NJ. Isolation and characterization of the Hamster gadd153 gene: activation of promoter activity by agents that damage DNA. Mol Cell Biol. 1989;9:4196-203.
5. Barone MV, Crozat A, Tabace A, Philipson L, Ron D. CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev. 1994;8:453-64.
6. Matsumoto M, Minami M, Takeda K, Sakao Y, Akira S. Ectopic expression of CHOP (GADD 153) induces apoptosis in M1 myeloblastic leukemia cells. FEBS Lett. 1996;395:143-7.
7. Wang X-Z, Lawson B, Brewer JW, et al. Signal from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153). Mol Cell Biol. 1996;16:4273-80.
8. Ron D, Habener JF. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Gene Dev. 1992;6:439-53.
9. Carlson SG, Fawcett TW, Bartlett JD, Bernie M, Holbrook NJ. Regulation of the C/EBP-related gene gadd153 by glucose deprivation. Mol Cel Biol. 1993;13:4736-44.
10. Batchvarova N, Wang X-Z, Ron D. Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153). EMBO J. 1995;14:4654-61.
11. Adelmant G, Gilbert JD, Freytag SO. Human translocation liposarcoma-CCAAT/enhancer binding protein (C/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C/EBPβ function. J Biol Chem. 1998;273:15574-81.
12. Tang Q-Q, Lane MD. Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-ß during adipogenesis. Proc Natl Acad Sci U S A. 2000;97:12446-50.
13. Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306:457-61.
14. Carriere A, Carmona M-C, Fernandez Y, et al. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem. 2004;279:40462-9.
15. Oyadomari S, Takeda K, Takiguchi M, et al. Nitric oxide-induced apoptosis in pancreatic ß cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci U S A. 2001;98:10845-50.
16. Oyadomari S, Koizumi A, Takeda K, et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest. 2002;109:525-32.
17. Ma K, Cabrero A, Saha PK, et al. Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem. 2002;277:34658-61.
18. Oh-I S, Shimizu H, Sato T, Uehara Y, Okada S, Mori M. Molecular mechanisms associated with leptin resistance: n-3 polyunsaturated fatty acids induce alterations in the tight junction of the brain. Cell Metab. 2005;1:331-41.
19. Tomaru T, Sato T, Yoshino S, et al. Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma. Endocrinology. 2006;147:377-88.
20. Shimizu H, Saito T, Mori M. An increase of serum remnant-like particle in non-insulin dependent diabetic patients with microalbuminuria. Clin Chim Acta. 1993;221:191-6.
21. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes. 1988;37:1163-7.
22. Bluher M, Patti ME, Gesta S, Kahn BB, Kahn CR. Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knock-out mice is associated with differences in patterns of gene expression. J Biol Chem. 2004;279:31891-901.
23. Wang L, Shao X, Muhlenkamp P, et al. Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein beta. J Biol Chem. 2000;275:4173-81.
24. Lin F-T, MacDougald OA, Diehl AM, Lane MD. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein α message: transcriptional activator lacking anti-mitotic activity. Proc Natl Acad Sci U S A. 1993;90:9606-10.
25. Calkhoven CF, Muller C, Leutz A. Translational control of C/EBPa and C/EBPß isoform expression. Gene & Dev. 2000;14:1920-32.
26. 3H]estradiol in rat adipose tissues. Am J Physiol. 1981;240:E43-6.
27. Shimizu H, Shimomura Y, Nakanishi Y, et al. Estrogen increases in vivo leptin production in rats and human subjects. J Endocrinol. 1997;154:285-92.
28. Jones ME, Thorburn AW, Britt KL, et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 2000;97:12735-740.
29. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A. 2000;97:12729-34.
30. Gentry RT, Wade GN. Sex differences in sensitivity of food intake, body weight, and running-wheel activity to ovarian steroids in rats. J Comp Physiol Psychol. 1976;90:747-54.
31. Qiu Y, Langman MJS, Eggo MC. Target of 17ß-estradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy? J Endocrinol. 2004;181:327-37.